$YMTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in YUMANITY THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in YUMANITY THERAPEUTICS, INC.. Get notifications about new insider transactions in YUMANITY THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | YMTX | YUMANITY THERAPEUT ... | Smith Devin Whittemore | SVP and General Cou ... | Option Exercise | A | 16.20 | 58,400 | 946,080 | 58,400 | |
Apr 15 2021 | YMTX | YUMANITY THERAPEUT ... | Verma Ajay | EVP, Head of R&D | Option Exercise | A | 17.60 | 84,000 | 1,478,400 | 84,000 | |
Apr 02 2021 | YMTX | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 19.64 | 78,650 | 1,544,686 | 78,650 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Epstein Marie | Principal Accountin ... | Option Exercise | A | 8.16 | 4,216 | 34,403 | 4,216 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Epstein Marie | Principal Accountin ... | Option Exercise | A | 8.16 | 38,373 | 313,124 | 38,373 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | PICKETT CECIL B | Director | Option Exercise | A | 8.16 | 5,271 | 43,011 | 5,271 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | PICKETT CECIL B | Director | Grant | A | 0.00 | 6,158 | 0 | 6,158 | 0 to 6.2 K |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Peters Richard | President and CEO | Option Exercise | A | 8.16 | 235,237 | 1,919,534 | 235,237 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Robertson Brigitte | Chief Medical Offic ... | Option Exercise | A | 8.16 | 59,035 | 481,726 | 59,035 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Mohsen Paulash | Chief Business Offi ... | Option Exercise | A | 8.16 | 10,542 | 86,023 | 10,542 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Mohsen Paulash | Chief Business Offi ... | Option Exercise | A | 8.16 | 42,168 | 344,091 | 42,168 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Mohsen Paulash | Chief Business Offi ... | Grant | A | 0.00 | 36,428 | 0 | 36,428 | 0 to 36.4 K |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Kelly Jeffery W. | Director | Option Exercise | A | 8.16 | 5,271 | 43,011 | 5,271 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Kelly Jeffery W. | Director | Grant | A | 0.00 | 6,158 | 0 | 11,278 | 5.1 K to 11.3 K (+120.27 %) |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Allen Patricia L | Director | Option Exercise | A | 8.16 | 5,271 | 43,011 | 5,271 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Allen Patricia L | Director | Option Exercise | A | 8.16 | 12,495 | 101,959 | 12,495 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Zydowsky Lynne | Director | Option Exercise | A | 8.16 | 5,271 | 43,011 | 5,271 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Zydowsky Lynne | Director | Option Exercise | A | 8.16 | 12,495 | 101,959 | 12,495 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Heyman Richard A. | Director | Option Exercise | A | 8.16 | 5,271 | 43,011 | 5,271 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Heyman Richard A. | Director | Grant | A | 0.00 | 6,158 | 0 | 6,158 | 0 to 6.2 K |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Arkowitz David | Director | Grant | A | 23.00 | 4,347 | 99,981 | 4,347 | 0 to 4.3 K |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 24.05 | 6,038 | 145,214 | 6,038 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 8.16 | 12,082 | 98,589 | 12,082 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 8.16 | 72,496 | 591,567 | 72,496 | |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Grant | A | 0.00 | 52,669 | 0 | 52,669 | 0 to 52.7 K |
Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Grant | A | 0.00 | 689,890 | 0 | 689,890 | 0 to 689.9 K |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Kelly Jeffery W. | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Chowdhury Badrul A. | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Dulac Emmanuel | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Drapkin Kimberlee C | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Arkowitz David | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Mar 04 2020 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | Chief Commercial Of ... | Option Exercise | A | 1.57 | 118,600 | 186,202 | 118,600 | |
Mar 04 2020 | PTI | PROTEOSTASIS THERA ... | Wilson Sheila | Chief Operating Off ... | Option Exercise | A | 1.57 | 145,800 | 228,906 | 145,800 | |
Mar 04 2020 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | Chief Scientific Of ... | Option Exercise | A | 1.57 | 132,500 | 208,025 | 132,500 | |
Mar 04 2020 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Option Exercise | A | 1.57 | 406,800 | 638,676 | 406,800 | |
Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.52 | 1,166,755 | 2,941,739 | 4,270,691 | 5.4 M to 4.3 M (-21.46 %) |
Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.45 | 117,164 | 287,134 | 5,437,446 | 5.6 M to 5.4 M (-2.11 %) |
Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.52 | 1,166,755 | 2,941,739 | 4,270,691 | 5.4 M to 4.3 M (-21.46 %) |
Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.45 | 117,164 | 287,134 | 5,437,446 | 5.6 M to 5.4 M (-2.11 %) |
Jul 01 2019 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 0.94 | 15,300 | 14,382 | 15,300 | |
Jul 01 2019 | PTI | PROTEOSTASIS THERA ... | Kelly Jeffery W. | Director | Option Exercise | A | 0.94 | 15,300 | 14,382 | 15,300 | |
May 14 2019 | PTI | PROTEOSTASIS THERA ... | Chowdhury Badrul A. | Director | Option Exercise | A | 1.09 | 30,600 | 33,354 | 30,600 | |
Mar 08 2019 | PTI | PROTEOSTASIS THERA ... | Arkowitz David | Director | Option Exercise | A | 4.07 | 30,600 | 124,542 | 30,600 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | Chief Commercial Of ... | Option Exercise | A | 4.30 | 137,500 | 591,250 | 137,500 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Wilson Sheila | Chief Operating Off ... | Option Exercise | A | 4.30 | 137,500 | 591,250 | 137,500 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Option Exercise | A | 4.30 | 142,900 | 614,470 | 142,900 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Option Exercise | A | 4.30 | 53,450 | 229,835 | 53,450 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | Chief Commercial Of ... | Option Exercise | A | 4.30 | 137,500 | 591,250 | 137,500 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Wilson Sheila | Chief Operating Off ... | Option Exercise | A | 4.30 | 137,500 | 591,250 | 137,500 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Option Exercise | A | 4.30 | 142,900 | 614,470 | 142,900 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Option Exercise | A | 4.30 | 53,450 | 229,835 | 53,450 | |
Mar 05 2019 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Option Exercise | A | 4.30 | 367,700 | 1,581,110 | 367,700 | |
Feb 07 2019 | PTI | PROTEOSTASIS THERA ... | Dulac Emmanuel | Director | Option Exercise | A | 3.11 | 30,600 | 95,166 | 30,600 | |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | Chief Operating Off ... | Option Exercise | M | 0.00 | 22,313 | 0 | 0 | |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | Chief Operating Off ... | Buy | M | 0.00 | 22,313 | 0 | 22,313 | 0 to 22.3 K |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | Chief Scientific Of ... | Option Exercise | M | 0.00 | 24,953 | 0 | 0 | |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | Chief Scientific Of ... | Sell | S | 2.99 | 9,514 | 28,454 | 15,439 | 25 K to 15.4 K (-38.13 %) |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | Chief Scientific Of ... | Buy | M | 0.00 | 24,953 | 0 | 24,953 | 0 to 25 K |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Option Exercise | M | 0.00 | 26,046 | 0 | 0 | |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Sell | S | 2.99 | 9,931 | 29,700 | 18,427 | 28.4 K to 18.4 K (-35.02 %) |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Buy | M | 0.00 | 26,046 | 0 | 28,358 | 2.3 K to 28.4 K (+1,126.56 %) |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Option Exercise | M | 0.00 | 24,100 | 0 | 0 | |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Sell | S | 2.99 | 9,189 | 27,480 | 14,911 | 24.1 K to 14.9 K (-38.13 %) |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Buy | M | 0.00 | 24,100 | 0 | 24,100 | 0 to 24.1 K |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Option Exercise | M | 0.00 | 46,875 | 0 | 0 | |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Sell | S | 2.99 | 16,478 | 49,305 | 80,615 | 97.1 K to 80.6 K (-16.97 %) |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Buy | M | 0.00 | 46,875 | 0 | 97,093 | 50.2 K to 97.1 K (+93.34 %) |
Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Drapkin Kimberlee C | Director | Option Exercise | A | 3.00 | 30,600 | 91,800 | 30,600 | |
Jan 30 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Sell | S | 3.00 | 712 | 2,136 | 2,312 | 3 K to 2.3 K (-23.54 %) |
Jan 30 2019 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Sell | S | 3.00 | 1,600 | 4,800 | 3,024 | 4.6 K to 3 K (-34.60 %) |
Oct 26 2018 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 6.75 | 40,000 | 270,000 | 40,000 | 0 to 40 K |
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 3.19 | 15,300 | 48,807 | 15,300 | |
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | Rabinowitz Eric | Director | Option Exercise | A | 3.19 | 45,900 | 146,421 | 45,900 | |
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | Kelly Jeffery W. | Director | Option Exercise | A | 3.19 | 15,300 | 48,807 | 15,300 | |
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 3.19 | 15,300 | 48,807 | 15,300 | |
Mar 05 2018 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | Chief Scientific Of ... | Option Exercise | A | 3.11 | 78,800 | 245,068 | 78,800 | |
Mar 05 2018 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Option Exercise | A | 3.11 | 29,900 | 92,989 | 29,900 | |
Mar 05 2018 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Option Exercise | A | 3.11 | 240,800 | 748,888 | 240,800 | |
Mar 05 2018 | PTI | PROTEOSTASIS THERA ... | Boudreau Helen M | Chief Financial Off ... | Option Exercise | A | 3.11 | 78,000 | 242,580 | 78,000 | |
Feb 05 2018 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Option Exercise | A | 0.00 | 26,046 | 0 | 26,046 | |
Feb 05 2018 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Option Exercise | A | 0.00 | 46,875 | 0 | 46,875 | |
Feb 05 2018 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | Chief Business Offi ... | Option Exercise | A | 0.00 | 22,313 | 0 | 22,313 | |
Feb 05 2018 | PTI | PROTEOSTASIS THERA ... | Boudreau Helen M | Chief Financial Off ... | Option Exercise | A | 0.00 | 13,759 | 0 | 13,759 | |
Feb 05 2018 | PTI | PROTEOSTASIS THERA ... | Gilmartin Geoffrey S. | Chief Development O ... | Option Exercise | A | 0.00 | 24,100 | 0 | 24,100 | |
Feb 05 2018 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | Chief Scientific Of ... | Option Exercise | A | 0.00 | 24,953 | 0 | 24,953 | |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 5.00 | 2,000,000 | 10,000,000 | 5,554,610 | 3.6 M to 5.6 M (+56.26 %) |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 5.00 | 2,000,000 | 10,000,000 | 5,554,610 | 3.6 M to 5.6 M (+56.26 %) |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Buy | P | 5.00 | 40,000 | 200,000 | 50,218 | 10.2 K to 50.2 K (+391.47 %) |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | Kelly Jeffery W. | Director | Buy | P | 5.00 | 4,000 | 20,000 | 102,411 | 98.4 K to 102.4 K (+4.06 %) |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 5.00 | 60,000 | 300,000 | 266,162 | 206.2 K to 266.2 K (+29.10 %) |
Dec 18 2017 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | S | 4.88 | 504,027 | 2,461,164 | 3,300,000 | 2.8 M to 3.3 M (+18.03 %) |
Aug 07 2017 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 2.20 | 63,663 | 140,059 | 63,663 | |
Aug 07 2017 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 2.20 | 63,663 | 140,059 | 63,663 | |
Aug 07 2017 | PTI | PROTEOSTASIS THERA ... | Kelly Jeffery W. | Director | Option Exercise | A | 2.20 | 63,663 | 140,059 | 63,663 | |
Aug 03 2017 | PTI | PROTEOSTASIS THERA ... | Boudreau Helen M | Chief Financial Off ... | Option Exercise | A | 2.25 | 215,000 | 483,750 | 215,000 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | See Remarks | Option Exercise | A | 7.56 | 60,000 | 453,600 | 60,000 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | See Remarks | Option Exercise | A | 7.56 | 60,000 | 453,600 | 60,000 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | See Remarks | Option Exercise | A | 7.56 | 59,500 | 449,820 | 59,500 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Munoz Benito | See Remarks | Option Exercise | A | 7.56 | 59,500 | 449,820 | 59,500 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Option Exercise | A | 7.56 | 69,400 | 524,664 | 69,400 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Lee Po Shun | See Remarks | Option Exercise | A | 7.56 | 69,400 | 524,664 | 69,400 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Hagen Brett R | See Remarks | Option Exercise | A | 7.56 | 21,100 | 159,516 | 21,100 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Hagen Brett R | See Remarks | Option Exercise | A | 7.56 | 21,100 | 159,516 | 21,100 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Gilmartin Greffrey S. | Chief Development O ... | Option Exercise | A | 7.56 | 35,700 | 269,892 | 35,700 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Gilmartin Greffrey S. | Chief Development O ... | Option Exercise | A | 7.56 | 35,700 | 269,892 | 35,700 | |
Apr 05 2017 | PTI | PROTEOSTASIS THERA ... | Chhabra Meenu | President and CEO | Option Exercise | A | 7.56 | 225,000 | 1,701,000 | 225,000 | |
Mar 15 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | Sell | S | 12.94 | 25,000 | 323,500 | 243,508 | 268.5 K to 243.5 K (-9.31 %) | |
Mar 13 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 12.04 | 25,000 | 301,000 | 268,508 | 293.5 K to 268.5 K (-8.52 %) |
Mar 10 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 11.96 | 800 | 9,568 | 293,508 | 294.3 K to 293.5 K (-0.27 %) |
Mar 10 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 11.91 | 400 | 4,764 | 294,308 | 294.7 K to 294.3 K (-0.14 %) |
Mar 10 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 11.86 | 400 | 4,744 | 294,708 | 295.1 K to 294.7 K (-0.14 %) |
Mar 10 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 11.78 | 200 | 2,356 | 295,108 | 295.3 K to 295.1 K (-0.07 %) |
Mar 10 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 11.97 | 2,500 | 29,925 | 295,308 | 297.8 K to 295.3 K (-0.84 %) |
Mar 10 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 12.10 | 25,000 | 302,500 | 297,808 | 322.8 K to 297.8 K (-7.74 %) |
Mar 08 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 13.59 | 4,897 | 66,550 | 322,808 | 327.7 K to 322.8 K (-1.49 %) |
Mar 08 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 12.67 | 30,103 | 381,405 | 327,705 | 357.8 K to 327.7 K (-8.41 %) |
Mar 08 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 13.31 | 25,000 | 332,750 | 357,808 | 382.8 K to 357.8 K (-6.53 %) |
Mar 06 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 13.63 | 20,000 | 272,600 | 382,808 | 402.8 K to 382.8 K (-4.97 %) |
Mar 06 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 14.58 | 4,500 | 65,610 | 402,808 | 407.3 K to 402.8 K (-1.10 %) |
Mar 06 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 14.03 | 20,500 | 287,615 | 407,308 | 427.8 K to 407.3 K (-4.79 %) |
Mar 02 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 14.70 | 30,000 | 441,000 | 427,808 | 457.8 K to 427.8 K (-6.55 %) |
Mar 02 2017 | PTI | PROTEOSTASIS THERA ... | FMR LLC | 10% Owner | Sell | S | 14.47 | 15,000 | 217,050 | 457,808 | 472.8 K to 457.8 K (-3.17 %) |
Dec 19 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 11.52 | 14,000 | 161,342 | 206,162 | 192.2 K to 206.2 K (+7.29 %) |
Dec 19 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 10.99 | 26,000 | 285,626 | 192,162 | 166.2 K to 192.2 K (+15.65 %) |
Dec 14 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.98 | 21,301 | 233,955 | 3,804,027 | 3.8 M to 3.8 M (+0.56 %) |
Dec 14 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.79 | 100,000 | 1,078,950 | 3,782,726 | 3.7 M to 3.8 M (+2.72 %) |
Dec 09 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.93 | 21,819 | 238,482 | 3,682,726 | 3.7 M to 3.7 M (+0.60 %) |
Dec 09 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.74 | 22,598 | 242,707 | 3,660,907 | 3.6 M to 3.7 M (+0.62 %) |
Dec 06 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.89 | 8,216 | 89,441 | 3,638,309 | 3.6 M to 3.6 M (+0.23 %) |
Dec 06 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.78 | 29,757 | 320,882 | 3,630,093 | 3.6 M to 3.6 M (+0.83 %) |
Dec 06 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.48 | 50,000 | 523,800 | 3,600,336 | 3.6 M to 3.6 M (+1.41 %) |
Dec 01 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.11 | 41,984 | 424,593 | 3,550,336 | 3.5 M to 3.6 M (+1.20 %) |
Dec 01 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.28 | 128,407 | 1,319,523 | 3,508,352 | 3.4 M to 3.5 M (+3.80 %) |
Nov 23 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 10.67 | 200 | 2,134 | 3,379,945 | 3.4 M to 3.4 M (+0.01 %) |
Nov 23 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 11.37 | 180,300 | 2,050,372 | 3,379,745 | 3.2 M to 3.4 M (+5.64 %) |
Nov 23 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 11.08 | 69,500 | 769,817 | 3,199,445 | 3.1 M to 3.2 M (+2.22 %) |
Nov 23 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 11.64 | 111,863 | 1,302,622 | 3,129,945 | 3 M to 3.1 M (+3.71 %) |
Nov 14 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 11.48 | 9,500 | 109,016 | 3,018,082 | 3 M to 3 M (+0.32 %) |
Nov 14 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 11.46 | 21,200 | 242,975 | 3,008,582 | 3 M to 3 M (+0.71 %) |
Nov 14 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 11.07 | 216,700 | 2,398,587 | 2,987,382 | 2.8 M to 3 M (+7.82 %) |
Nov 14 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 9.68 | 12,100 | 117,121 | 2,770,682 | 2.8 M to 2.8 M (+0.44 %) |
Nov 07 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 8.69 | 231,700 | 2,012,616 | 2,758,582 | 2.5 M to 2.8 M (+9.17 %) |
Nov 07 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 8.09 | 73,403 | 594,021 | 2,526,882 | 2.5 M to 2.5 M (+2.99 %) |
Nov 07 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 7.27 | 2,597 | 18,880 | 2,453,497 | 2.5 M to 2.5 M (+0.11 %) |
Nov 07 2016 | PTI | PROTEOSTASIS THERA ... | Cormorant Asset Management, LL ... | 10% Owner | Buy | P | 7.24 | 20,277 | 146,763 | 2,450,882 | 2.4 M to 2.5 M (+0.83 %) |
Nov 02 2016 | PTI | PROTEOSTASIS THERA ... | Gilmartin Greffrey S. | See Remarks | Option Exercise | A | 6.98 | 75,000 | 523,500 | 75,000 | |
Nov 02 2016 | PTI | PROTEOSTASIS THERA ... | Zecevic Marija | See Remarks | Option Exercise | A | 6.98 | 56,000 | 390,880 | 56,000 | |
Sep 15 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 13.00 | 461,538 | 5,999,994 | 3,554,610 | 3.1 M to 3.6 M (+14.92 %) |
Sep 15 2016 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 13.00 | 461,538 | 5,999,994 | 3,554,610 | 3.1 M to 3.6 M (+14.92 %) |